Trials / Sponsors / Amyndas Pharmaceuticals S.A.
Amyndas Pharmaceuticals S.A.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE) Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19) | Phase 2 | 2021-09-01 |
| Completed | A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis Gingivitis | Phase 1 / Phase 2 | 2019-07-22 |
| Completed | First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers Complement Mediated Diseases | Phase 1 | 2017-04-24 |